Showing 501 - 520 results of 694 for search '"dementia"', query time: 0.05s Refine Results
  1. 501

    Consultations on driving in people with cognitive impairment in primary care: A scoping review of the evidence. by Carol Sinnott, Tony Foley, Justin Forsyth, Kathleen McLoughlin, Linda Horgan, Colin P Bradley

    Published 2018-01-01
    “…<h4>Participants</h4>PCPs or their equivalent and/ or individuals with cognitive impairment across the spectrum of mild cognitive impairment to dementia.<h4>Measurements</h4>Systematic search of Medline, Cinahl, PsychINFO, Academic Search Complete, Psychological and Behavioural Sciences Collection, SocIndex and Social Sciences FT were conducted. …”
    Get full text
    Article
  2. 502

    Dietary Fatty Acids and Predementia Syndromes by Vincenzo Solfrizzi, Vincenza Frisardi, Cristiano Capurso, Alessia D' Introno, Anna M. Colacicco, Gianluigi Vendemiale, Antonio Capurso, Francesco Panza

    Published 2009-01-01
    “…Therefore, at present, no definitive dietary recommendations on fish and unsaturated fatty acids consumption, or lower intake of saturated fat, in relation to the risk for dementia and cognitive decline are possible.…”
    Get full text
    Article
  3. 503

    Transformative Service Research and the role of service robots: a bibliometric analysis by Priscila Pasti Barbosa, Felipe Facco Mendes Ferreira, Larissa Cayla Cesário, Glauco Henrique de Souza Mendes

    Published 2025-01-01
    “…The analysis of several use cases of service robots in elderly care is carried out in the article to highlight the importance of using this service in cases of great importance, such as in cases of dementia. Cultural sensitivity and personalization of robots emerged as essential factors for increasing user acceptance and scalability, particularly in diverse healthcare environments. …”
    Get full text
    Article
  4. 504

    Estimating the potential health effects of cleaner air in the initial stages of the COVID-19 pandemic: a study in Malmö, Sweden by Ebba Malmqvist, Emilie Stroh, Erin Flanagan, Christina Isaxon, Pontus Roldin, Anna Oudin

    Published 2024-12-01
    “…If sustained, such improvements could lead to an estimated 1–3% decrease in premature deaths, a 2% decrease in preeclampsia cases, a 6% decrease in low birthweight children, a 4% decrease in bronchitis cases among children, a 2% decrease in asthma cases, a 0.2% decrease in hospital admissions for respiratory diagnoses, and an estimated 11% decrease in dementia cases annually. Conclusion The findings illustrate the potential for enhanced health in Malmö due to improved air quality. …”
    Get full text
    Article
  5. 505

    Emerging targets of α-synuclein spreading in α-synucleinopathies: a review of mechanistic pathways and interventions by Grace Kuo, Ramhari Kumbhar, William Blair, Valina L. Dawson, Ted M. Dawson, Xiaobo Mao

    Published 2025-01-01
    “…Abstract α-Synucleinopathies constitute a spectrum of neurodegenerative disorders, including Parkinson’s disease (PD), Lewy body dementia (LBD), Multiple System Atrophy (MSA), and Alzheimer’s disease concurrent with LBD (AD-LBD). …”
    Get full text
    Article
  6. 506

    Impact of Alzheimer’s Disease on Caregivers in the United States by Megan Vu, Rohan Mangal, Thor Stead, Carlos Lopez-Ortiz, Latha Ganti

    Published 2022-08-01
    “…As patients’ symptoms of dementia continue to worsen, they gradually grow more limited in their independence. …”
    Get full text
    Article
  7. 507

    Brain targeting based nanocarriers loaded with resveratrol in Alzheimer's disease: A review by Cyrus Jalili, Amir Kiani, Mohammadreza Gholami, Fariborz Bahrehmand, Sajad Fakhri, Somayeh Kakehbaraei, Seyran Kakebaraei

    Published 2023-05-01
    “…Abstract Alzheimer's disease (AD) is one of the chief neurological difficulties in the aged population, identified through dementia, memory disturbance, and reduced cognitive abilities. β‐amyloid (Aβ) plaques aggregations, generation of reactive oxygen species, and mitochondrial dysfunction are among the major signs of AD. …”
    Get full text
    Article
  8. 508

    Advanced Magnetic Resonance Imaging for Early Diagnosis and Monitoring of Movement Disorders by Emmanuel Ortega-Robles, Benito de Celis Alonso, Jessica Cantillo-Negrete, Ruben I. Carino-Escobar, Oscar Arias-Carrión

    Published 2025-01-01
    “…These techniques enable earlier and more accurate differentiation of movement disorders, including Parkinson’s disease, progressive supranuclear palsy, multiple system atrophy, corticobasal degeneration, Lewy body and frontotemporal dementia, Huntington’s disease, and dystonia. Furthermore, MRI provides objective metrics for tracking disease progression and assessing therapeutic efficacy, making it an indispensable tool in clinical trials. …”
    Get full text
    Article
  9. 509

    The antioxidant potential of bacoside and its derivatives in Alzheimer's disease: The molecular mechanistic paths and therapeutic prospects by Dipanjan Karati, Swarupananda Mukherjee, Souvik Roy

    Published 2025-06-01
    “…The key physiological dysfunctions linked to tau aggregates, which contribute to dementia and behavioral inconsistencies, include the formation of reactive oxygen species, augmented neuronal swelling, and neurotoxicity. …”
    Get full text
    Article
  10. 510

    Hyperhomocysteinemia-induced VCID results in visual deficits, reduced neuroinflammation and vascular alterations in the retina by Erica M. Weekman, Colin B. Rogers, Tiffany L. Sudduth, Donna M. Wilcock

    Published 2025-01-01
    “…Abstract Over recent years, the retina has been increasingly investigated as a potential biomarker for dementia. A number of studies have looked at the effect of Alzheimer’s disease (AD) pathology on the retina and the associations of AD with visual deficits. …”
    Get full text
    Article
  11. 511

    Mutations in human prion-like domains: pathogenic but not always amyloidogenic by Andrea Bartolomé-Nafría, Javier García-Pardo, Salvador Ventura

    Published 2024-12-01
    “…To date, over 60 mutations targeting the LCDs of hnRNPs have been identified and associated with a spectrum of neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and Alzheimer’s disease (AD). The cryo-EM structures of pathological and functional fibrils formed by different hnRNPs have been recently elucidated, including those of hnRNPA1, hnRNPA2, hnRNPDL-2, TDP-43, and FUS. …”
    Get full text
    Article
  12. 512

    Identification of Potential Herbal Inhibitor of Acetylcholinesterase Associated Alzheimer’s Disorders Using Molecular Docking and Molecular Dynamics Simulation by Chandrabhan Seniya, Ghulam Jilani Khan, Kuldeep Uchadia

    Published 2014-01-01
    “…Additionally, acetylcholinesterase (AChE) is the target for many Alzheimer’s dementia drugs which block the function of AChE but have some side effects. …”
    Get full text
    Article
  13. 513

    Recognizing Cognitive and Psychiatric Changes in the Post-Highly Active Antiretroviral Therapy Era by Adriana Carvalhal, Jean-Guy Baril, Frederic Crouzat, Joss De Wet, Patrice Junod, Colin Kovacs, Nancy Sheehan

    Published 2012-01-01
    “…Specifically addressed in the present review are the International HIV Dementia Scale, a novel screening equation and algorithm for HAND, as well as brief, validated, verbal questionnaires for detection of depression and substance abuse. …”
    Get full text
    Article
  14. 514

    Influence of immune cells and inflammatory factors on Alzheimer’s disease axis: evidence from mediation Mendelian randomization study by Linzhu, Jianxin Zhang, Wenhui Fan, Chen Su, Zhi Jin

    Published 2025-02-01
    “…Abstract Background Alzheimer’s disease (AD) is one of the most common forms of dementia in the elderly, characterized by progressive neurodegeneration. …”
    Get full text
    Article
  15. 515

    Transforming Alzheimer’s Disease Diagnosis: Implementing Vision Transformer (ViT) for MRI Images Classification by Dian Kurniasari, Muhammad Dwi Pratama, Akmal Junaidi, Ahmad Faisol

    Published 2025-01-01
    “… Alzheimer’s disease (AD) is a progressive neurological disorder and the leading cause of dementia, accounting for 60-80% of cases. Early detection of AD is crucial for timely intervention, as the disease significantly impacts cognitive functions and daily activities. …”
    Get full text
    Article
  16. 516

    Diogenes Syndrome: A Case Report by Projna Biswas, Anusree Ganguly, Sanchaita Bala, Falguni Nag, Nidhi Choudhary, Sumit Sen

    Published 2013-01-01
    “…These patients may have psychiatric disorders like paranoid disorders, mood affection, or temporofrontal dementia. Subjects are mainly the elderly but few cases in younger age group of patients have also been reported. …”
    Get full text
    Article
  17. 517

    Oligonucleotide-Based Therapy for FTD/ALS Caused by the C9orf72 Repeat Expansion: A Perspective by Stephanie A. Fernandes, Andrew G. L. Douglas, Miguel A. Varela, Matthew J. A. Wood, Yoshitsugu Aoki

    Published 2013-01-01
    “…Amyotrophic lateral sclerosis (ALS) is a progressive and lethal disease of motor neuron degeneration, leading to paralysis of voluntary muscles and death by respiratory failure within five years of onset. Frontotemporal dementia (FTD) is characterised by degeneration of frontal and temporal lobes, leading to changes in personality, behaviour, and language, culminating in death within 5–10 years. …”
    Get full text
    Article
  18. 518

    APOE4 and sedentary lifestyle synergistically impair neurovascular function in the visual cortex of awake mice by Silvia Anderle, Orla Bonnar, Joseph Henderson, Kira Shaw, Andre M. Chagas, Letitia McMullan, Alexandra Webber, Kirsty McGowan, Sarah L. King, Catherine N. Hall

    Published 2025-01-01
    “…Promotion of physical activity may therefore be particularly important to improve cerebrovascular function and reduce dementia risk in APOE4 carriers.…”
    Get full text
    Article
  19. 519

    The role of microRNAs in learning and long-term memory by L. N. Grinkevich

    Published 2020-12-01
    “…Moreover, impaired microRNA biogenesis is one of the causes of the pathogenesis of mental disorders, neurodegenerative illnesses and senile dementia, which are often accompanied by deterioration in the learning ability and by memory impairment. …”
    Get full text
    Article
  20. 520

    Metabolic Derangements Contribute to Reduced sRAGE Isoforms in Subjects with Alzheimer’s Disease by Kelly N. Z. Fuller, Edwin R. Miranda, John P. Thyfault, Jill K. Morris, Jacob M. Haus

    Published 2018-01-01
    “…Cognitively healthy elderly and AD participants with and without type 2 diabetes (n=135) were stratified according to the clinical dementia rating (CDR; 0 = normal cognition (NC); ≥0.5 = AD). …”
    Get full text
    Article